Table of Contents
<< Previous Issue | Aug-Sep 03 2003 (Vol: 2003, Issue: 39) | Next Issue >> |
- Section: Company Profile
-
Epigenomics AG
-
GPC Biotech AG
- Section: Distribution & Marketing
-
SkyePharma License Marketing and Distribution Rights for DepoCyte® to Mundipharma
- Section: General
-
Millennium, J&J and Velcade
-
Quid Pro Quo Deals
-
Therapy Focus: Migraine
- Section: Licensing
-
Boehringer Licenses Medivir’s MIV-310 Antiviral Drug
-
Pozen and Nycomed Enter into Option Agreement for NSAID Lornoxicam
- Section: Mergers & Acquisitions
-
Roche Acquires Cardion’s IL-15 Antagonist
-
Genzyme Expands Immunology Portfolio Through Sangstat Acquisition
- Section: Research & Development
-
Aventis and ImmunoGen Enter Anticancer Antibody Collaboration